Salbutamol Improves Diaphragmatic Contractility in Chronic Airway Obstruction;El salbutamol mejora la contractilidad diafragmática en la obstrucción crónica de la vía aérea

Archivos de Bronconeumologia

Volumn 45, Issue 5, 2009, Pages 230-234

  Angulo, Martín ^a   Taranto, Eliseo ^a   Soto, Juan Pablo ^a   Malacrida, Leonel ^a   Nin, Nicolás ^a   Hurtado, F Javier ^a   Píriz, Héctor ^a  

^a DEPARTAMENTO DE BIOQUÍMICA   (Uruguay)

Author keywords

COPD; Diaphragm; Salbutamol; Tracheal banding

Indexed keywords

BICARBONATE; SALBUTAMOL;

ACID BASE BALANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL CARBON DIOXIDE TENSION; ARTERIAL GAS; ARTERIAL OXYGEN SATURATION; ARTICLE; BICARBONATE BLOOD LEVEL; BLOOD PH; BLOOD SAMPLING; BREATHING MUSCLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTINUOUS INFUSION; CONTROL GROUP; CONTROLLED STUDY; DIAPHRAGM MUSCLE; FUNCTIONAL ASSESSMENT; IN VITRO STUDY; MUSCLE CONTRACTILITY; MUSCLE CONTRACTION; MUSCLE RELAXATION; MUSCLE STRENGTH; NONHUMAN; RAT; VELOCITY;

EID: 67349160183     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1016/S1579-2129(09)72153-6     Document Type: Article

References (32)

1. Keens T., Chen V., Patel V., O'Brien P., Levison H., and Ianuzzo C. Cellular adaptations of the ventilatory muscles to a chronic increased respiratory load. J Appl Physiol 44 (1978) 905-908
2. Prezant D., Aldrich T., Richner B., Gentry E., Valentine D., Nagashima H., et al. Effects of long-term continuous respiratory resistive loading on rat diaphragm function and structure. J Appl Physiol 74 (1993) 1212-1219
3. Reid W., Huang J., Bryson S., Walker D., and Belcastro A. Diaphragm injury and myofibrillar structure induced by resistive loading. J Appl Physiol 76 (1994) 176-184
4. Supinski G., Nethery D., Stofan D., Hirschfield W., and DiMarco A. Diaphragmatic lipid peroxidation in chronically loaded rats. J Appl Physiol 86 (1999) 651-658
5. Reid W., and Belcastro A. Time course of diaphragm injury calpain activity during resistive loading. Am J Respir Crit Care 162 (2000) 1801-1806
6. Levine S., Kaiser L., Leferovich J., and Tikunov B. Cellular adaptations in the diaphragm in chronic obstructive pulmonary disease. N Engl J Med 337 (1997) 1799-1806
7. Macgowan N., Evans K., Road J., and Reid D. Diaphragm injury in individuals with airflow obstruction. Am J Respir Crit Care Med 163 (2001) 1654-1659
8. Wijnhover J., Janssen A.J., Van Kuppevelt T., Rodenburg R., and Dekhuijzen P. Metabolic capacity of the diaphragm in patients with COPD. Respir Med 100 (2006) 1064-1071
9. Barreiro E., De la Puente B., Minguella J., Corominas J., Serrano S., Hussain S., et al. Oxidative stress and respiratory muscle dysfunction in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 171 (2005) 1116-1124
10. Ottenheijm C., Heunks L., Li Y., Jin B., Minnaard R., Van Hees H., and Dekhuijzen P. Activation of the ubiquitin-proteasome pathway in the diaphragm in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 174 (2006) 997-1002
11. Ottenheijm C., Heunks L., Sieck G., Zhan W., Jansen S., Degens H., et al. Diaphragm dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 172 (2005) 200-205
12. Gea J., and Barreiro E. Actualización en los mecanismos de disfunción muscular en la EPOC. Arch Bronconeumol 44 (2008) 328-337
13. Van der Heijden H., Van Balkom R., Folgering H., Van Herwaarden C., and Dekhuijzen P. Effects of salbutamol on rat diaphragm contractility. J Appl Physiol 81 (1996) 1103-1110
14. Van der Heijden H., Dekhuijzen P., Folgering H., and Van Herwaarden C. Inotropic effects of salbutamol on rat diaphragm contractility are potentiated by foreshortening. Am J Respir Crit Care Med 155 (1997) 1072-1079
15. Van der Heijden H., Zhan W., Prakash Y., Dekhuijzen P., and Sieck G. Salbutamol enhances isotonic contractile properties of rat diaphragm muscle. J Appl Physiol 85 (1998) 525-529
16. Píriz H., Nin N., Boggia J., Angulo M., and Hurtado F.J. El salbutamol mejora la fuerza diafragmática en la sepsis experimental. Arch Bronconeumol 44 (2008) 135-139
17. Hatipoglu U., Laghi F., and Tobin M. Does inhaled albuterol improve diaphragmatic contractility in patients with chronic obstructive pulmonary disease?. Am J Respir Crit Care Med 160 (1999) 1916-1921
18. Carter W., and Lynch M. Comparison of the effects of salbutamol and clenbuterol on skeletal muscle mass and carcass composition in senescent rats. Metabolism 43 (1994) 1119-1125
19. Reid W., Noonan J., Chung F., and Tesler-Mabe C. Ventilatory failure induced by tracheal banding in the hamster. J Appl Physiol 73 (1992) 1671-1675
20. 2 sobre el diafragma de rata in vitro. Arch Bronconeumol 30 (1994) 445-448
21. Statement of the American Thoracic Society and European Respiratory Society. Skeletal muscle dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 159 (1999) S1-S40
22. Xu X., Zhou J., Yang Q., Fang L., Xie Q., and Shen Y. An in vitro rat diaphragmatic fatigue model induced by combined hypoxic and hypercapnic acidosis and de effect of salmeterol. Pharmacol Res 53 (2006) 171-176
23. Vassilakopoulos T., Divangahi M., Rallis G., Kishta O., Petrof B., Comtois A., et al. Differential cytokine gene expression in the diaphragm in response to strenuous resistive breathing. Am J Respir Crit Care Med 170 (2004) 154-161
24. Reid M., Lannergren J., and Westerblad H. Respiratory and limb muscle weakness induced by tumor necrosis factor-alpha: involvement of muscle myofilaments. Am J Respir Crit Care Med 166 (2002) 479-484
25. Takahashi H., Morichika T., Iwagaki H., Yoshino T., Tamura R., Saito S., et al. Effect of beta 2-adrenergic receptor stimulation on interleukin-18-induced intercellular adhesion molecule-1 expression and cytokine production. J Pharmacol Exp Ther 304 (2003) 634-642
26. 2-adrenergic receptor stimulation-induced immunosuppressive effects possibly through down-regulation of co-stimulatory molecules, ICAM-1, CD40 and CD14 on monocytes. J Int Med Res 32 (2004) 465-483
27. 2-agonists have antioxidant function in vitro. 1. Inhibition of superoxide anion, hydrogen peroxide, hypochlorous acid and hydroxyl radical. Respiration 64 (1997) 16-22
28. Zwicker K., Damerau W., Dikalov S., Scholtyssek H., Schimke I., and Zimmer G. Superoxide radical scavenging by phenolic bronchodilators under aprotic and aqueous conditions. Biochem Pharmacol 56 (1998) 301-305
29. Nazir Mirza Z., Kato M., Kimura H., Tachibana A., Fujiu T., Suzuki M., et al. Fenoterol inhibits superoxide anion generation by human polymorphonuclear leukocytes via Beta-2-adrenoceptor-dependent and -independent mechanisms. Ann Allergy Asthma Immunol 88 (2002) 494-500
30. Choo J., Horan M., Little A., and Rothwell N. Anabolic effects of clenbuterol on skeletal muscle are mediated by beta 2 adrenoceptor activation. Am J Physiol 263 (1992) E50-6
31. Yimlamai T., Dodd S., Borst S., and Park S. Clenbuterol induces muscle-specific attenuation of atrophy through effects on the ubiquitin-proteasome pathway. J Appl Physiol 99 (2005) 71-80
32. Busquets S., Figueras M., Fuster G., Almendro V., Moore-Carrasco R., Ametller E., et al. Anticachectic effects of formoterol: a drug for potential treatment of muscle wasting. Cancer Res 64 (2004) 6725-6731